Finance

Lists
7EY:FRA
Kiora Pharmaceuticals Inc
0.00%
(0.00) 1D
Oct 4, 11:46:04 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 7EY...
Mkt. cap
11.24M
Volume
0.00
52-wk high
€0.42
52-wk low
€0.42
No. of employees
13
Mkt. cap
11.24M
Volume
0.00
52-wk high
€0.42
52-wk low
€0.42
No. of employees
13
News stories
From web sources and news partners
About Kiora Pharmaceuticals Inc
CEO-
Employees13
Founded1998
HeadquartersEncinitas, California, United States
SectorPharmaceutical industry
Websitekiorapharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
1.07M
1.17M
890.50K
740.85K
Cost of revenue
1.07M
1.17M
890.50K
740.85K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.44M
1.46M
1.61M
1.38M
Operating expense
1.44M
1.46M
1.61M
1.38M
Total operating expenses
2.52M
2.63M
2.50M
2.12M
Operating income
-2.52M
-2.63M
-2.50M
-2.12M
Other non operating income
-23.71K
173.24K
-47.13K
-11.47K
EBT including unusual items
-616.32K
-7.17M
-2.42M
-2.08M
EBT excluding unusual items
-2.34M
-2.49M
-2.41M
-1.99M
Income tax expense
-643.13K
-649.97K
-
-
Effective tax rate
104.35%
9.07%
-
-
Other operating expenses
-
-
-
-
Net income
26.81K
-6.52M
-2.42M
-2.08M
Net profit margin
-
-
-
-
Earnings per share
0.01
-
-
-
Interest and investment income
201.82K
190.31K
139.34K
146.23K
Interest expense
-
-19.96K
-
-
Net interest expenses
201.82K
170.35K
139.34K
146.23K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.50M
-2.62M
-2.49M
-2.11M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps